Microvascular function and rheologic changes in hyperdynamic sepsis.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMID 7867351)

Published in Crit Care Med on February 01, 1995

Authors

M E Astiz1, G E DeGent, R Y Lin, E C Rackow

Author Affiliations

1: Department of Medicine, St. Vincent's Hospital and Medical Center of New York, NY 10011.

Articles citing this

Bench-to-bedside review: sepsis is a disease of the microcirculation. Crit Care (2004) 1.66

Microvascular dysfunction as a cause of organ dysfunction in severe sepsis. Crit Care (2005) 1.42

Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction? Crit Care (2003) 1.18

Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: an observational study. Crit Care (2009) 1.10

Assessment of tissue oxygen saturation during a vascular occlusion test using near-infrared spectroscopy: the role of probe spacing and measurement site studied in healthy volunteers. Crit Care (2009) 1.07

Extravascular lung water correlates multiorgan dysfunction syndrome and mortality in sepsis. PLoS One (2010) 0.96

Early goal-directed resuscitation of patients with septic shock: current evidence and future directions. Crit Care (2015) 0.95

Recombinant activated protein C treatment improves tissue perfusion and oxygenation in septic patients measured by near-infrared spectroscopy. Crit Care (2009) 0.91

Monitoring the microcirculation. J Clin Monit Comput (2012) 0.90

The effect of red blood cell transfusion on tissue oxygenation and microcirculation in severe septic patients. Ann Intensive Care (2011) 0.88

Red blood cell clearance in inflammation. Transfus Med Hemother (2012) 0.87

Paradoxical Roles of the Neutrophil in Sepsis: Protective and Deleterious. Front Immunol (2016) 0.81

Physiopathology of shock. J Emerg Trauma Shock (2011) 0.80

Brachial artery reactivity in patients with severe sepsis: an observational study. Crit Care (2012) 0.79

Nociceptin system as a target in sepsis? J Anesth (2014) 0.76

Near-infrared spectroscopy StO2 monitoring to assess the therapeutic effect of drotrecogin alfa (activated) on microcirculation in patients with severe sepsis or septic shock. Ann Intensive Care (2013) 0.75

Effects of volume resuscitation on the microcirculation in animal models of lipopolysaccharide sepsis: a systematic review. Intensive Care Med Exp (2016) 0.75

Effects of non-leukocyte-reduced and leukocyte-reduced packed red blood cell transfusions on oxygenation of rat spinotrapezius muscle. Microvasc Res (2013) 0.75

Characterization of hypoalbuminemia following temporary abdominal closure. J Trauma Acute Care Surg (2017) 0.75

Articles by these authors

(truncated to the top 100)

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA (1994) 5.24

Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med (2000) 3.00

End-tidal carbon dioxide concentration during cardiopulmonary resuscitation. N Engl J Med (1988) 2.80

Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med (1983) 2.36

Decreases in mortality on a large urban medical service by facilitating access to critical care. An alternative to rationing. Arch Intern Med (1988) 1.86

Venous hypercarbia associated with severe sepsis and systemic hypoperfusion. Crit Care Med (1990) 1.74

Cardiac output and end-tidal carbon dioxide. Crit Care Med (1985) 1.71

Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors. J Gastroenterol Hepatol (1997) 1.68

Difference in acid-base state between venous and arterial blood during cardiopulmonary resuscitation. N Engl J Med (1986) 1.66

Relationship of oxygen delivery and mixed venous oxygenation to lactic acidosis in patients with sepsis and acute myocardial infarction. Crit Care Med (1988) 1.58

Expired carbon dioxide: a noninvasive monitor of cardiopulmonary resuscitation. Circulation (1988) 1.50

Effect of crystalloid and colloid solutions on blood rheology in sepsis. Shock (1997) 1.48

Alterations in C3, C4, factor B, and related metabolites in septic shock. Clin Immunol Immunopathol (1993) 1.44

Unaccounted for anion in metabolic acidosis during severe sepsis in humans. Crit Care Med (1991) 1.40

Competent and continuing care of the critically ill. Crit Care Med (1988) 1.39

The first decade of the American Board of Internal Medicine certification in critical care medicine: an overview of examinees and certificate holders from 1987 through 1996. Crit Care Med (2000) 1.38

Monophosphoryl lipid A attenuates the effects of endotoxic shock in pigs. J Lab Clin Med (1992) 1.38

Organelle-specific targeting of protein kinase AII (PKAII). Molecular and in situ characterization of murine A kinase anchor proteins that recruit regulatory subunits of PKAII to the cytoplasmic surface of mitochondria. J Biol Chem (1997) 1.29

Septic shock. Lancet (1998) 1.26

Arteriovenous carbon dioxide and pH gradients during cardiac arrest. Circulation (1986) 1.24

Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med (2001) 1.19

Acute pulmonary edema in Plasmodium falciparum malaria. Am Rev Respir Dis (1978) 1.19

Genotyping of human cystic echinococcosis in Xinjiang, PR China. Parasitology (2006) 1.17

Decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients. J Lab Clin Med (2000) 1.15

Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med (1983) 1.14

Arterial PCO2 as an indicator of systemic perfusion during cardiopulmonary resuscitation. Crit Care Med (1989) 1.13

Comparison of blood lactate concentrations in central venous, pulmonary artery, and arterial blood. Crit Care Med (1987) 1.12

Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression. Chest (1993) 1.12

End-tidal CO2 as a guide to successful cardiopulmonary resuscitation: a preliminary report. Crit Care Med (1985) 1.11

Buffer agents do not reverse intramyocardial acidosis during cardiac resuscitation. Circulation (1990) 1.10

Triage considerations in medical intensive care. Arch Intern Med (1990) 1.07

Cardiopulmonary resuscitation in the rat. J Appl Physiol (1985) (1988) 1.06

A model of scarless human fetal wound repair is deficient in transforming growth factor beta. J Pediatr Surg (1995) 1.04

Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial. Crit Care Med (1995) 1.03

Effects of hetastarch and albumin on coagulation in patients with septic shock. J Clin Pharmacol (1988) 1.01

Oxygen delivery and consumption in patients with hyperdynamic septic shock. Crit Care Med (1987) 1.00

The fetal fibroblast: the effector cell of scarless fetal skin repair. Plast Reconstr Surg (1995) 0.99

The relationship of the colloid osmotic-pulmonary artery wedge pressure gradient to pulmonary edema and mortality in critically ill patients. Chest (1982) 0.99

Relationships between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsis. Crit Care Med (1994) 0.98

Unusual autoimmune manifestations in furosemide-associated hypersensitivity angiitis. N Y State J Med (1988) 0.96

Myocardial acidosis associated with CO2 production during cardiac arrest and resuscitation. Circulation (1989) 0.96

Microvascular response in patients with cardiogenic shock. Crit Care Med (2000) 0.94

Prolongation of the half-life of lactate after maximal exercise in patients with hepatic dysfunction. Crit Care Med (1989) 0.94

'Lactate washout' following circulatory arrest. JAMA (1988) 0.94

The spectrum of pulmonary edema: differentiation of cardiogenic, intermediate, and noncardiogenic forms of pulmonary edema. Am Rev Respir Dis (1981) 0.94

Pulmonary edema; a complication of diabetic ketoacidosis. Chest (1980) 0.93

Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Crit Care Med (1982) 0.93

Neurogenic pulmonary edema. Chest (1982) 0.91

Early impairment of oxidative metabolism and energy production in severe sepsis. Circ Shock (1988) 0.91

Intramyocardial hypercarbic acidosis during cardiac arrest and resuscitation. Crit Care Med (1993) 0.91

Improved survival in patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure. Chest (1989) 0.90

Non-ICU care of hemodynamically stable mechanically ventilated patients. Chest (1996) 0.90

In vivo reduction of circulating C1q binding immune complexes by intravenous gammaglobulin administration. Int Arch Allergy Appl Immunol (1986) 0.89

Monophosphoryl lipid A protects against gram-positive sepsis and tumor necrosis factor. Shock (1994) 0.89

GB virus-C/hepatitis G virus infection in prostitutes: possible role of sexual transmission. J Med Virol (1997) 0.89

Colloid osmotic pressure as a prognostic indicator of pulmonary edema and mortality in the critically ill. Chest (1977) 0.88

The relationship between oxygen delivery and consumption during fluid resuscitation of hypovolemic and septic shock. Chest (1984) 0.88

Topical zinc sulfate augmentation of human delayed type skin test response. Acta Derm Venereol (1985) 0.88

Uremic pulmonary edema. Am J Med (1978) 0.87

Influence of rheologic changes and platelet-neutrophil interactions on cell filtration in sepsis. Am J Respir Crit Care Med (2000) 0.86

Comparison of the induction of endotoxin tolerance in endotoxemia and peritonitis by monophosphoryl lipid A and lipopolysaccharide. Circ Shock (1993) 0.85

Acid-base determinants of survival after cardiopulmonary resuscitation. Crit Care Med (1985) 0.85

Adverse effects of febrile state on cardiac performance. Am Heart J (1983) 0.85

Induction of endotoxin tolerance with monophosphoryl lipid A in peritonitis: importance of localized therapy. J Lab Clin Med (1994) 0.84

Reversible impairment of myocardial contractility due to hypercarbic acidosis in the isolated perfused rat heart. Crit Care Med (1991) 0.84

Cardiac effects of carbon dioxide-consuming and carbon dioxide-generating buffers during cardiopulmonary resuscitation. J Am Coll Cardiol (1990) 0.84

An outbreak of PCB poisoning. J Dermatol (1980) 0.84

Septic encephalopathy. Evidence for altered phenylalanine metabolism and comparison with hepatic encephalopathy. Arch Intern Med (1990) 0.84

Fatal frontal sinusitis due to Neisseria sicca and Eubacterium lentum. J Otolaryngol (1986) 0.84

Delayed lactate clearance in patients surviving circulatory shock. Acute Care (1985) 0.84

Colloid and crystalloid fluid resuscitation. Acute Care (1985) 0.83

Intravascular volume and fluid therapy for severe sepsis. New Horiz (1993) 0.83

The arterial anatomy of larynx transplantation: microsurgical revascularization of the larynx. Clin Anat (1996) 0.83

Training and certification of critical care medicine in the United States. Chest (1988) 0.83

Serum sickness syndrome. Am Fam Physician (1986) 0.83

Skeletal muscle blood flow and venous capacitance in patients with severe sepsis and systemic hypoperfusion. Chest (1989) 0.82

Subcorneal pustular dermatosis with polyarthritis. Cutis (1986) 0.81

End tidal carbon dioxide as an haemodynamic determinant of cardiopulmonary resuscitation in the rat. Cardiovasc Res (1989) 0.81

Effects of tromethamine and sodium bicarbonate buffers during cardiac resuscitation. J Clin Pharmacol (1988) 0.81

Effects of crystalloid and colloid fluids on extravascular lung water in hypoproteinemic dogs. J Appl Physiol (1985) (1987) 0.81

Assessing perfusion failure during circulatory shock. Crit Care Clin (1993) 0.80

Monophosphoryl lipid A stimulated up-regulation of reactive oxygen intermediates in human monocytes in vitro. J Leukoc Biol (2001) 0.80

Incomplete global myocardial ischemia during cardiac arrest and resuscitation. Crit Care Med (1988) 0.80

Echocardiographic observations during cardiopulmonary resuscitation: a preliminary report. Crit Care Med (1985) 0.80

HIV type 1 env subtype A variants in Taiwan. AIDS Res Hum Retroviruses (1998) 0.80

Dermatofibrosarcoma protuberans arising in a site of multiple immunizations. Arch Dermatol (1979) 0.80

Lymphocytic interstitial pneumonitis in adult HIV infection. N Y State J Med (1988) 0.80

Domestic transmission of HIV type 1 subtype G strains in Taiwan. AIDS Res Hum Retroviruses (1999) 0.80

Effects of proinflammatory cytokines and bacterial toxins on neutrophil rheologic properties. Crit Care Med (1998) 0.79

Hemodynamic response to fluid repletion in patients with septic shock: evidence for early depression of cardiac performance. Circ Shock (1987) 0.79

HIV type 1 env gene diversity detected in Taiwan. AIDS Res Hum Retroviruses (1997) 0.79

Increases in coronary vein CO2 during cardiac resuscitation. J Appl Physiol (1985) (1990) 0.79

Inotropic response to digoxin and dopamine in patients with severe sepsis, cardiac failure, and systemic hypoperfusion. Chest (1989) 0.78

Neutrophil rheologic changes in septic shock. Am J Respir Crit Care Med (1997) 0.78

An improved scheme for the identification of antigens recognized by specific antibodies in two-dimensional gel electrophoresis and immunoblotting. Electrophoresis (1990) 0.78

Molecular epidemiology and trends of HIV-1 subtypes in Taiwan. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.78

Monophosphoryl lipid A stimulated up-regulation of nitric oxide synthase and nitric oxide release by human monocytes in vitro. Immunopharmacology (1997) 0.78

Monophosphoryl lipid A induces tolerance to the lethal hemodynamic effects of endotoxemia. Circ Shock (1991) 0.78

Diphosphoryl lipid A from Rhodopseudomonas sphaeroides induces tolerance to endotoxic shock in the rat. Crit Care Med (1993) 0.78

Suppressor function of T lymphocytes in the acquired immunodeficiency syndrome as assessed by allogeneic mixed lymphocyte culture. J Clin Lab Immunol (1985) 0.78